About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MELT - MRI Evaluation of Lymphoma Treatment | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01459224

MELT - MRI Evaluation of Lymphoma Treatment

Patients who are newly diagnosed with Hodgkin's lymphoma will undergo disease staging at diagnosis and initial treatment response assessment. At each time point (initial staging and treatment response...

Lead sponsor: University College, London•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University College, London

The trial will be a single centre cohort study in patients newly diagnosed with Hodgkin's lymphoma undergoing disease staging at diagnosis and initial treatment response assessment. At each time point (initial staging and treatment response assessment) in addition to standard imaging investigations (PET CT, Chest CT, anatomical MRI of the abdomen and pelvis and abdominal USS), patients will undergo advanced anatomical and functional MRI sequences.

Age

5 - 20 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Aged 5 to 20 years (inclusive) with participant and parent/guardian informed consent
•Histologically confirmed first presentation of Hodgkin's Lymphoma
•Either entered into the Euronet PHL-C1 trial or LP1 trials OR not formally entered into the Euronet trials but treated on the chemotherapy regimens of the Euronet trials for classical and lymphocyte predominant Hodgkin Lymphoma

Exclusion Criteria

•Contraindications to MRI (e.g. pacemaker)
•Previous malignancy or previous chemotherapy or radiotherapy treatment for malignancy
•Pregnancy or nursing

Related studies

Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial

NCT06923397 · Lymphoma, Lymphoma, Hodgkin, and more

RECRUITINGPhase 2

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

NCT05800210 · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and more

Active Not RecruitingNA

Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG

NCT04892667 · Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin

STAY-STRONG Study of Exercise Training During Chemotherapy

NCT05556239 · Lymphoma, B-Cell, Lymphoma, Hodgkin, and more

WITHDRAWNPhase 1/2

Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas

NCT03417765 · Lymphoma, Non-Hodgkin's, Adult, Lymphoma, Hodgkin's, Adult

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 3, 2015Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment58

Start dateSep 2011

Last updatedDec 3, 2015

Condition

Lymphoma, Hodgkin

Locations shown

University College London Hospital (UCLH)

London

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 3, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions